Multinational, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Efficacy and Safety of Prostaglandin E1 in Subjects With Critical Limb Ischemia (Fontaine Stage IV)
Каталог · ЕАЭС
Клинические исследования и проекты
UCB BIOSCIENCES GmbH · найдено 2
2 исследования
Завершено
Фаза IV
Россия
Alprostadil · UCB BIOSCIENCES GmbH
Завершено
Фаза III
Россия
Cimzia · UCB BIOSCIENCES GmbH
A Phase IIIb, Multinational, Open-label, follow-on Trial to C87085 Designed to Assess the Long-term Safety of Certolizumab Pegol, a Pegylated Fab' Fragment of a Humanized Anti-TNF-alpha Monoclonal Antibody, Administered at Weeks 0, 2 and 4, and Then Every 4 Weeks Thereafter, in Subjects With Moderately to Severely Active Crohn's Disease Who Have Participated in Study C87085